Apish, re TRMA. They reported 0.81 fd, ft in the most recent quarter, but did a secondary that will dilute immediately:
"* Subsequent to the end of the third quarter, the Company raised
$95.8 million of proceeds, net of underwriting discounts but before
offering expenses, from its public offering of 4,273,500 primary
shares of common stock.
4.3MM / 10.6MM = 41% additional dilution. If they had all those shares counted in Q3, then reported eps would have been reduced to 0.58